Sponsor Pipeline

Gan and Lee Pharmaceuticals, USA Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06558708 A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD)… Type 2 Diabetes Recruiting
Phase 1
NCT06548906 A Study of GZR4 Injection at Different Injection Sites Healthy Subjects Recruiting
NCT07146347 Comparison Study of Insulin GZR4 With Insulin Degludec Type 2 Diabetes Recruiting
NCT07242664 Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady… Type 1 Diabetes Mellitis Recruiting
NCT06554054 A Study of GZR18 Tablet in Chinese Healthy Subjects Diabetes Mellitus, Type 2 Active, Not Recruiting
NCT06670209 A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the… Type 2 Diabetes Not Yet Recruiting
Disease Areas
Diabetes (5) Type 2 Diabetes (3) Type 1 Diabetes (1)
Get alerts when Gan and Lee Pharmaceuticals, USA's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free